
COVID-19 Antibody Testing Update: Elitza Theel, Ph.D.
About this episode
(01:07)
Has the utility or the role of antibody testing changed or evolved in any way for you over the past months or since the pandemic began?
(04:06)
What do we know about the antibody response to the virus and how is our knowledge grown in that area? I think one question that people have is do we all make antibodies to the virus and how long do those antibodies last, and will they protect us from re-infection?
(06:41)
You mentioned briefly there's a neutralizing antibody test that recently received FDA emergency use authorization. Can you tell us a little bit about that and how you envision that test being used?
(10:33)
Can we reach herd immunity based on natural infection alone?
(11:56)
Once we have a vaccine, do you envision antibody testing being used to confirm that vaccination was successful? That people develop an antibody response because of the vaccine?
(14:10)
And would you say, out of all the antibody tests, how many of them are spike — that detect antibodies to the spike protein? It's all of them, right?
Resources
COVID-19 Testing Resource Center
Get every episode summarized
Each time Answers from the Lab publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Answers from the Lab

Unique Assays Advance Care of Complex Autoimmune Skin Conditions
Answers from the Lab

Digital Advances: What’s Next for Clinical Diagnostics?
Answers from the Lab

Preeclampsia Test Helps Extend Pregnancy to Improve Outcomes
Answers from the Lab

Breakthrough Test Enhances Peripheral Neuropathy Care and Research
Answers from the Lab